Coherus BioSciences, Inc.
NASDAQ:CHRS
1.05 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 102.891 | 63.547 | 417.195 | 541.158 | 177.668 | 72.356 | 126.911 | 124.947 | 158.226 | 150.392 | 39.554 | 14.548 |
| Short Term Investments
| 14.857 | 128.134 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 117.748 | 191.681 | 417.195 | 541.158 | 177.668 | 72.356 | 126.911 | 124.947 | 158.226 | 150.392 | 39.554 | 14.548 |
| Net Receivables
| 260.522 | 109.964 | 123.022 | 157.046 | 141.992 | -1.742 | 0 | 1.859 | 1.56 | 4.232 | 0.385 | 0.158 |
| Inventory
| 62.605 | 115.051 | 93.252 | 92.189 | 55.071 | 1.659 | 0 | -4.845 | -4.357 | -8.199 | 0 | 10.033 |
| Other Current Assets
| 34.756 | 22.918 | 24.464 | 25.042 | 13.542 | 0.083 | 0.142 | 2.986 | 2.797 | 3.967 | 5.738 | 0.06 |
| Total Current Assets
| 475.631 | 416.696 | 633.469 | 790.393 | 374.731 | 72.356 | 126.911 | 124.947 | 158.226 | 150.392 | 45.677 | 24.799 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 11.031 | 8.754 | 7.813 | 20.064 | 16.489 | 6.66 | 12.773 | 10.772 | 10.504 | 4.472 | 1.743 | 1.605 |
| Goodwill
| 0.943 | 0.9 | 0.943 | 0.943 | 0.943 | 0.943 | 0.943 | 0.943 | 0.943 | 0.943 | 0 | 0 |
| Intangible Assets
| 70.73 | 5.031 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 0 | 0 |
| Goodwill and Intangible Assets
| 71.673 | 5.931 | 3.563 | 3.563 | 3.563 | 3.563 | 3.563 | 3.563 | 3.563 | 3.563 | 0 | 0 |
| Long Term Investments
| 0.452 | 0.44 | 0.44 | 0.44 | 0.24 | 0.785 | 0.785 | 0.785 | 0.785 | 0 | 0 | 0 |
| Tax Assets
| 0 | -0.44 | -0.44 | -0.44 | -0.24 | -0.785 | -0.785 | -0.785 | -0.785 | 0 | 0 | 0 |
| Other Non-Current Assets
| 70.817 | 49.466 | 34.489 | 27.629 | 14.144 | 16.888 | 19.364 | 39.203 | 40.091 | 28.794 | 0.027 | 0.129 |
| Total Non-Current Assets
| 153.973 | 64.151 | 45.865 | 51.256 | 34.196 | 27.111 | 35.7 | 53.538 | 54.158 | 36.829 | 1.77 | 1.734 |
| Total Assets
| 629.604 | 480.847 | 679.334 | 841.649 | 408.927 | 99.467 | 162.611 | 178.485 | 212.384 | 187.221 | 47.447 | 26.533 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 35.219 | 11.526 | 16.159 | 15.201 | 25.985 | 15.294 | 15.714 | 20.583 | 29.496 | 10.798 | 3.685 | 3.902 |
| Short Term Debt
| 2.145 | 4.318 | 3.492 | 3.133 | 2.196 | 0 | 0.233 | 0.877 | 24.133 | 11.231 | 4.203 | 1.738 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | -3.133 | -2.196 | 0 | 8.817 | 1.962 | 50.951 | 23.992 | 14.283 | 2.025 |
| Other Current Liabilities
| 294.407 | 38.617 | 59.376 | 66.328 | 88.984 | 17.967 | 3.631 | 32.954 | 1.438 | 5.762 | 31.53 | 3.588 |
| Total Current Liabilities
| 331.771 | 54.461 | 79.027 | 81.529 | 114.969 | 33.261 | 28.395 | 56.376 | 106.018 | 51.783 | 53.701 | 11.253 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 473.369 | 471.058 | 408.28 | 404.023 | 178.386 | 103.092 | 101.41 | 100.256 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 5.328 | 0 | 0 | 0 | 0 | 0 | 0 | 1.561 | 94.959 | 62.699 | 28.567 | 6.076 |
| Deferred Tax Liabilities Non-Current
| 1.102 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 11.459 | 92.746 | 94.301 | 75.123 | 125.327 | 34.966 | 30.666 | 57.314 | 124.354 | 57.765 | 7.561 | 0.012 |
| Total Non-Current Liabilities
| 491.258 | 563.804 | 502.581 | 479.146 | 303.713 | 138.058 | 132.076 | 159.131 | 219.313 | 120.464 | 36.128 | 6.088 |
| Total Liabilities
| 823.029 | 618.265 | 581.608 | 560.675 | 303.713 | 138.058 | 132.076 | 159.131 | 219.313 | 120.464 | 89.829 | 17.341 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 187.221 | 54.695 | 54.695 |
| Common Stock
| 0.011 | 0.008 | 0.007 | 0.007 | 0.007 | 0.007 | 0.006 | 0.005 | 0.004 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -1,579.5 | -1,341.608 | -1,049.854 | -762.754 | -894.998 | -984.831 | -775.492 | -537.322 | -409.985 | -186.725 | -99.592 | -45.957 |
| Accumulated Other Comprehensive Income/Loss
| -0.248 | -0.249 | -0.27 | -0.27 | -0.558 | -0.282 | -0.75 | -0.63 | -0.401 | -0.525 | -0.625 | -0.226 |
| Other Total Stockholders Equity
| 1,386.312 | 1,204.431 | 1,147.843 | 1,043.991 | 1,000.763 | 946.515 | 806.771 | 557.301 | 403.453 | 66.783 | 3.139 | 0.679 |
| Total Shareholders Equity
| -193.425 | -137.418 | 97.726 | 280.974 | 105.214 | -38.591 | 30.535 | 19.354 | -6.929 | 66.757 | -42.382 | 9.192 |
| Total Equity
| -193.425 | -137.418 | 97.726 | 280.974 | 105.214 | -38.591 | 29.246 | 18.181 | -7.651 | 66.713 | -42.382 | 9.192 |
| Total Liabilities & Shareholders Equity
| 629.604 | 480.847 | 679.334 | 841.649 | 408.927 | 99.467 | 162.611 | 178.485 | 212.384 | 187.221 | 47.447 | 26.533 |